Like PTPN2, PTPN1 regulates STAT5-dependent signalling in T cells, whilst the deletion of PTPN1 enhances the efficacy of CD8+ conventional T cell and CAR-T cell ACT in mouse models of cancer [29]. Here, PTPN2 is linked to cancer.